These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27236111)

  • 1. Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial.
    Metawee M; Charnigo R; Morales G; Darrat Y; Sorrell V; Di Biase L; Natale A; Delisle B; Elayi CS; ;
    Int J Cardiol; 2016 Sep; 218():176-180. PubMed ID: 27236111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
    Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
    Lopes RD; Pieper KS; Horton JR; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Ohman EM; White HD; Wallentin L; Granger CB
    Heart; 2008 Jul; 94(7):867-73. PubMed ID: 18332062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
    Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
    Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality.
    Jäger B; Farhan S; Rohla M; Christ G; Podczeck-Schweighofer A; Schreiber W; Laggner AN; Weidinger F; Stefenelli T; Delle-Karth G; Kaff A; Maurer G; Huber K;
    Eur Heart J Acute Cardiovasc Care; 2017 Apr; 6(3):254-261. PubMed ID: 26888787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.
    Magnesium in Coronaries (MAGIC) Trial Investigators
    Lancet; 2002 Oct; 360(9341):1189-96. PubMed ID: 12401244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the origin of the collateral feeding donor artery on short-term mortality in ST-elevation myocardial infarction with comorbid chronic total occlusion.
    Fujii T; Sakai K; Nakano M; Ohno Y; Nakazawa G; Shinozaki N; Matsukage T; Yoshimachi F; Ikari Y
    Int J Cardiol; 2016 Sep; 218():158-163. PubMed ID: 27232928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation on Admission Is Related With Higher Mortality in ST-Segment Elevation Myocardial Infarction Patients.
    Hwang KK; Eom SY; Lee SY; Kim SM; Cho MC; Kim YJ; Seung KB; Jeong MH; Bae JW;
    Int Heart J; 2017 Aug; 58(4):486-494. PubMed ID: 28690292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Leor J; Goldbourt U; Behar S; Boyko V; Reicher-Reiss H; Kaplinsky E; Rabinowitz B
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):609-17. PubMed ID: 8547212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial.
    Cooper HA; Domanski MJ; Rosenberg Y; Norman J; Scott JH; Assmann SF; McKinlay SM; Hochman JS; Antman EM;
    Am Heart J; 2004 Dec; 148(6):1012-9. PubMed ID: 15632887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial).
    Popovic B; Girerd N; Rossignol P; Agrinier N; Camenzind E; Fay R; Pitt B; Zannad F
    Am J Cardiol; 2016 Nov; 118(10):1442-1447. PubMed ID: 27677387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.
    Freeman JV; Reynolds K; Fang M; Udaltsova N; Steimle A; Pomernacki NK; Borowsky LH; Harrison TN; Singer DE; Go AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):49-58. PubMed ID: 25414270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Atrial Fibrillation Complicating ST-Segment Elevation Myocardial Infarction.
    Podolecki T; Lenarczyk R; Kowalczyk J; Jedrzejczyk-Patej E; Swiatkowski A; Chodor P; Sedkowska A; Streb W; Mitrega K; Kalarus Z
    Am J Cardiol; 2017 Aug; 120(4):517-521. PubMed ID: 28645470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme.
    Puymirat E; Lamhaut L; Bonnet N; Aissaoui N; Henry P; Cayla G; Cattan S; Steg G; Mock L; Ducrocq G; Goldstein P; Schiele F; Bonnefoy-Cudraz E; Simon T; Danchin N
    Eur Heart J; 2016 Apr; 37(13):1063-71. PubMed ID: 26578201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
    Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.